Caricamento...
Inhibition of Viral Replication Downregulates CD4(+)CD25(high) Regulatory T Cells and Programmed Death-Ligand 1 in Chronic Hepatitis B
Chronic hepatitis B is characterized by an impaired immune response to hepatitis B virus (HBV). Telbivudine treatment has significantly improved the clinical outcome of chronic HBV infection. However, the underlying mechanism behind the antiviral response of patients treated with nucleoside analogs...
Salvato in:
| Autori principali: | , , , , , , , , , |
|---|---|
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Mary Ann Liebert, Inc.
2012
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3271372/ https://ncbi.nlm.nih.gov/pubmed/22233255 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1089/vim.2011.0049 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|